Corporate Investor
Pubblicato il 20-10-2026 - Diasorin in Bresso
Obsessed by Science. Entrepreneurial by Nature. United by Purpose.
Diasorin is a global leader in immunodiagnostic and molecular diagnostic solutions, advancing science to improve patient outcomes worldwide. For more than 50 years, we have combined scientific rigor with an entrepreneurial mindset, operating with a strong commitment to innovation, accountability, and results to deliver trusted diagnostic solutions.
As the Diagnostics Specialist, Diasorin continuously invests in research, technology, and people. Guided by our values of operational excellence, customer focus, and teamwork, we empower teams to think boldly, act decisively, and transform ideas into meaningful impact across one of the industry’s broadest specialty diagnostic portfolios.
When you join Diasorin, you are not just filling a role. You are helping build what comes next.
Why Join Diasorin
Build What Matters Take ownership, challenge the status quo, and contribute directly to solutions that improve patient care worldwide.
Innovate with Agility at a Global Scale Work in an entrepreneurial environment that enables speed, collaboration, and global impact.
Grow in a People-Centered Culture Thrive in a culture that values accountability, inclusion, and continuous development.
Job Scope
The Investor & ESG Relations Analyst is responsible to ensure an appropriate and strategic positioning of the Company among the financial analysts, investors and all the stakeholders by enabling effective two-way communication.
Key Duties and Responsibilities
WITH FINANCIAL INVESTORS
Ongoing management of the investors’ base, through roadshows, attendance to financial conferences, periodic visits, etc.
Broadening of the existing investors’ base, through public presentations on the Company at the financial conferences, with one-to-one follow-ups via conference calls with new engaged investors.
Communication of ESG metrics, targets and actions in place.
WITH FINANCIAL ANALYSTS
Building the understanding of the Company amo